Grazoprevir eller et farmasøytisk akseptabelt stoff derav

摘要

The present invention relates to a macrocyclic compound of formula (I) useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections, in combination with other therapeutic agents.